Published date: 6 May 2022

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 16 March 2022, 12pm

Contract summary

Industry

  • Business and management consultancy and related services - 79400000

Location of contract

North East

Value of contract

£30,000

Procurement reference

NCL001-DN602760-35606861

Published date

6 May 2022

Closing date

16 March 2022

Closing time

12pm

Contract start date

25 April 2022

Contract end date

30 September 2022

Contract type

Service contract

Procedure type

Restricted procedure

A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No


Description

Caf1 is secreted from the bacterium Yersinia pestis to protect it from white blood cells during infection. It is formed from 15 kDa monomers that produce robust, flexible polymers up to 2 µm in length.

We aim to create a spinout company that will initially produce Caf1 polymers and coated plasticware/microcarriers for the 2D cell culture market, predominantly focussed on laboratory research, expanding into commercial companies looking to scale up cell production. The Newcastle-based company will supply these products directly to customers, and through marketing partners who have established distribution networks.

We are looking for a CEO/COO/Chairperson to work alongside Daniel Peters to develop a business plan that has considered the best market strategy for Caf1 in preparation for spinout formation and achieving the necessary fundraising.

The initial brief of the executive will be to:
(1) Work with the existing team to lead in the creation of a viable 5 year business plan;
(2) Obtain university approval for the venture;
(3) a. Act for the company in the spin-out legal process and address all company formation matters;
b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO or agreed post supporting Daniel Peters
c. Provide to the appropriate university all matters necessary for Research England reporting requirements;
(4) Leading and work alongside the existing team to secure start up funding (venture capital and other) funding
Stage (5) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 4 above


Award information

Awarded date

12 April 2022

Contract start date

25 April 2022

Contract end date

30 September 2022

Total value of contract

£29,500

This contract was awarded to 1 supplier.

KWWK Ltd

Address

Brunel House 340 Firecrest Court,
Centre Park,
Warrington,
Cheshire,
WA1 1RG,
United Kingdom

Reference

None

Supplier is SME?

Yes

Supplier is VCSE?

No


About the buyer

Contact name

Natalie Morton

Address

Newcastle University
Procurement Services, Kingsgate
Newcastle
NE1 7RU
United Kingdom

Telephone

+44 1912086396

Email

natalie.morton@ncl.ac.uk

Website

https://www.ncl.ac.uk